• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News

Our short URL is biophar.ma

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media Logo

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

immunotherapy

liver
Posted inOncology, Research

Tecentriq Plus Avastin: Most Effective Treatment for Unresectable Hepatocellular Carcinoma

Atezolizumab with bevacizumab: a powerful immunotherapy approach for first-line therapy of liver cancer.

Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma
Posted inNew Drugs, Oncology, Rare/Orphan Diseases, Regulatory

Kimmtrak: Groundbreaking Immuno-Oncological Treatment for Metastatic Uveal Melanoma

Tebentafusp is a pharmacological breakthrough in the fight against a deadly disease.

T cell.
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience

Even Severe Multiple Sclerosis Can Be Cured

Atara Biotherapeutics and its awesome T-cell therapy against Epstein–Barr virus can really cure progressive forms of multiple sclerosis.

Sanofi to Make Vaccine Against Acne
Posted inInfections, Pharma & Biotech

Sanofi to Make Vaccine Against Acne

Acne vulgaris treatment will reach a new level of quality.

GammaDelta Therapeutics.
Posted inMergers & Acquisitions, Oncology

Takeda Bets on Promising Gamma Delta T-cell Immunotherapy

UK-based GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies.

Posts navigation

1 2 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2022 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News